Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

NTRA

Natera Inc

Jun 18 • 04:00PM ET

107.99

Dollar change -2.43
Percentage change -2.20	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB VXF VBK XBI IBB SCHA IWP FBT VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.13	Insider Own	6.03%	Shs Outstand	119.58M	Perf Week	-3.98%
Market Cap	13.26B	Forward P/E	-	EPS next Y	-1.19	Insider Trans	-16.61%	Shs Float	115.40M	Perf Month	1.44%
Income	-365.46M	PEG	-	EPS next Q	-0.69	Inst Own	95.04%	Short Float	4.94%	Perf Quarter	18.33%
Sales	1.21B	P/S	10.97	EPS this Y	34.89%	Inst Trans	1.74%	Short Ratio	4.71	Perf Half Y	83.00%
Book/sh	6.50	P/B	16.62	EPS next Y	51.49%	ROA	-26.23%	Short Interest	5.70M	Perf Year	114.91%
Cash/sh	7.19	P/C	15.02	EPS next 5Y	-	ROE	-50.59%	52W Range	36.90 - 117.23	Perf YTD	72.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-11.28%	ROI	-32.01%	52W High	-7.88%	Beta	1.48
Dividend TTM	-	Quick Ratio	3.98	Sales past 5Y	33.95%	Gross Margin	50.28%	52W Low	192.66%	ATR (14)	3.48
Dividend Ex-Date	-	Current Ratio	4.12	EPS Y/Y TTM	41.37%	Oper. Margin	-31.63%	RSI (14)	51.98	Volatility	3.19% 3.05%
Employees	3293	Debt/Eq	0.55	Sales Y/Y TTM	39.26%	Profit Margin	-30.24%	Recom	1.47	Target Price	122.21
Option/Short	Yes / Yes	LT Debt/Eq	0.44	EPS Q/Q	54.33%	Payout	-	Rel Volume	0.70	Prev Close	110.42
Sales Surprise	16.26%	EPS Surprise	20.59%	Sales Q/Q	52.11%	Earnings	May 09 AMC	Avg Volume	1.21M	Price	107.99
SMA20	-1.37%	SMA50	6.67%	SMA200	50.50%	Trades		Volume	847,340	Change	-2.20%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Resumed	Jefferies	Buy	$142
Apr-08-24	Resumed	Craig Hallum	Buy	$117
Feb-20-24	Downgrade	Raymond James	Strong Buy → Outperform	$68 → $85
Dec-29-23	Reiterated	BTIG Research	Buy	$75 → $85
Dec-14-23	Initiated	Guggenheim	Buy	$70
Dec-13-23	Initiated	Wolfe Research	Outperform	$70
Nov-13-23	Upgrade	Raymond James	Outperform → Strong Buy	$68
Sep-28-23	Initiated	Bernstein	Mkt Perform	$48
Jul-05-23	Resumed	JP Morgan	Overweight	$85
May-05-23	Initiated	UBS	Buy	$76
Jan-18-23	Upgrade	Raymond James	Mkt Perform → Outperform	$58
Aug-25-22	Initiated	Credit Suisse	Outperform	$70
Apr-25-22	Initiated	Stephens	Overweight	$54
Mar-08-22	Initiated	Goldman	Buy	$90
Jan-06-22	Resumed	Piper Sandler	Overweight	$110
Oct-15-21	Resumed	Cowen	Outperform	$150
Jun-15-21	Initiated	Raymond James	Mkt Perform
May-25-21	Initiated	Wells Fargo	Overweight	$110
Jan-28-21	Initiated	Truist	Buy	$143
Oct-08-20	Initiated	BTIG Research	Buy	$90

Show Previous Ratings

Today 03:10AM	Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Jun-17-24 07:00AM	Natera Launches Differentiated New Feature for Prospera Heart Test, Enhancing Detection of Rejection for Transplant Patients (Business Wire)
Jun-10-24 02:25PM	Final Trades: Amazon, Natera and KKR (CNBC TV)
Jun-03-24 08:00AM	Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
02:42AM	Natera (NTRA) Raised Initial 2024 Guidance in Q1 (Insider Monkey)
Jun-01-24 03:24AM	Director Gail Marcus Sells 2,000 Shares of Natera Inc (NTRA) (GuruFocus.com)
May-31-24 03:13AM	Director Rowan Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-30-24 08:00AM	Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024 (Business Wire)
May-23-24 04:05PM	Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
07:30AM	Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting (Business Wire)
May-18-24 03:00AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia)
May-11-24 01:02AM	Decoding Natera Inc (NTRA): A Strategic SWOT Insight (GuruFocus.com)
May-10-24 04:01PM	Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise (Investor's Business Daily) +10.19%
01:58PM	Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs (The Wall Street Journal)
12:24PM	Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
12:17PM	Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 (Associated Press Finance)
12:04PM	Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:48AM	Natera Stock Charges Higher. Positive Cash Flow Arrived Early. (Barrons.com)
07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
06:00AM	Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life (InvestorPlace)
May-09-24 06:30PM	Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:47PM	Natera: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Natera Reports First Quarter 2024 Financial Results (Business Wire)
May-03-24 08:00AM	New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera in Breast Cancer (Business Wire)
May-02-24 02:14PM	NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:50AM	Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
02:49AM	Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
May-01-24 04:05PM	Natera to Report its First Quarter 2024 Results on May 9 (Business Wire)
07:00AM	Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage (Business Wire)
Apr-27-24 02:42AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (GuruFocus.com)
Apr-26-24 06:32PM	10 Cathie Wood Stocks Insiders are Selling (Insider Monkey)
Apr-24-24 08:36AM	Natera (NTRA) Rose on Momentum in the Oncology Market (Insider Monkey)
02:38AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
02:38AM	CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-22-24 08:00AM	Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications (Business Wire)
Apr-18-24 02:05AM	Insider Sell: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-17-24 08:31AM	TipRanks Perfect 10 List: Analysts See Opportunity in These 2 Top-Scoring Stocks (TipRanks)
Apr-11-24 08:00AM	Natera Announces Publication of Largest Prospective dd-cfDNA Study in Kidney Transplantation (Business Wire)
Apr-09-24 07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
Apr-08-24 08:00AM	Natera Announces New Data From Two Studies Extending the Clinical Validation of Its Prospera Heart dd-cfDNA Test for Heart Transplant Recipients (Business Wire)
Apr-05-24 07:00AM	Natera Announces Positive Surveillance Analysis from the Randomized Phase III IMvigor011 Trial in Muscle-Invasive Bladder Cancer (Business Wire)
05:15AM	Is Natera (NTRA) On The Cusp Of Being Cash Flow Positive? (Insider Monkey)
01:51AM	Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Apr-01-24 08:00AM	Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer (Business Wire)
Mar-21-24 10:25AM	11 Best Healthcare ETFs To Buy Now (Insider Monkey)
Mar-20-24 05:46AM	Will Natera (NTRA) Continue to Deliver Solid Topline Growth? (Insider Monkey)
Mar-18-24 03:39PM	Genetic Testing Stock Nears Buy Point After Earnings Gap-Up And 45% Gain (Investor's Business Daily)
07:00AM	Natera Announces Phase III Randomized CIRCULATE Trial in France, Evaluating Signatera in Stage II Colorectal Cancer (Business Wire)
Mar-14-24 08:00AM	New KDIGO Guideline Supports Genetic Testing for the Majority of CKD Patients to Establish Cause of Disease (Business Wire)
Mar-12-24 08:00AM	Natera to Present New Data at the 2024 SGO Annual Meeting on Womens Cancer, Following Recent Medicare Coverage Decisions in Ovarian and Breast Cancers (Business Wire)
Mar-11-24 02:22PM	Final Trades: Natera, Disney, Chubb and ASML Holding (CNBC TV)
Mar-08-24 01:31AM	SEC and Chief Legal Officer Daniel Rabinowitz Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Mar-07-24 08:00AM	Natera Announces Commercial Coverage for Prospera Kidney and Prospera Heart from a Top BCBS Plan (Business Wire)
Mar-04-24 12:00PM	What Makes Natera (NTRA) a Strong Momentum Stock: Buy Now? (Zacks)
Mar-01-24 12:09AM	Decoding Natera Inc (NTRA): A Strategic SWOT Insight (GuruFocus.com)
Feb-29-24 11:06AM	Q4 2023 Natera Inc Earnings Call (Thomson Reuters StreetEvents) +12.98%
08:12AM	Natera, Inc. (NASDAQ:NTRA) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM	Natera to Participate in March Investor Conferences (Business Wire)
Feb-28-24 06:30PM	Compared to Estimates, Natera (NTRA) Q4 Earnings: A Look at Key Metrics (Zacks)
04:32PM	Natera Inc (NTRA) Reports Significant Revenue Growth and Improved Gross Margins in Full Year 2023 (GuruFocus.com)
04:05PM	Natera Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 08:12AM	Natera (NTRA) Management Increased Full Year Guidance (Insider Monkey)
08:00AM	Natera Announces Next Phase of CareDx Patent Infringement Litigation Seeking Royalty For All Ongoing And Future AlloSure Tests (Business Wire)
01:07AM	Natera secures Medicare coverage for cancer test in 2 new indications (MedTech Dive)
Feb-26-24 07:00AM	Medicare Extends Coverage of Nateras Signatera MRD Test to Ovarian Cancer and Neoadjuvant Breast Cancer (Business Wire) +5.29%
Feb-20-24 08:00AM	Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call (Business Wire)
Feb-17-24 12:07AM	Natera Inc Director Herm Rosenman Sells 93,901 Shares (GuruFocus.com)
Feb-06-24 04:00PM	3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List (InvestorPlace)
Feb-05-24 08:00AM	New Study Validates Signatera in Endometrial Cancer (Business Wire)
Feb-02-24 11:02PM	Insider Sell: CFO Michael Brophy Sells 22,281 Shares of Natera Inc (GuruFocus.com)
Jan-31-24 05:02PM	Insider Sell: CFO Michael Brophy Sells 3,235 Shares of Natera Inc (GuruFocus.com)
Jan-30-24 09:15AM	Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 (GlobeNewswire)
07:00AM	New Publication Demonstrates Signateras Ability to Risk Stratify and Detect Recurrence Early in Resected Stage I-II Lung Cancer (Business Wire)
Jan-29-24 07:00AM	Jury Rules in Favor of Natera in Patent Infringement Lawsuit Against CareDx; Awards $96.3 Million in Damages to Natera in Lost Profits and Past Royalties (Business Wire)
Jan-25-24 07:00AM	Nature Medicine Publishes Two Studies Highlighting Signateras Clinical Utility in Patients with Gastrointestinal Malignancies (Business Wire)
Jan-24-24 12:20AM	Insider Sell: CFO Michael Brophy Sells 2,973 Shares of Natera Inc (NTRA) (GuruFocus.com)
Jan-22-24 07:00AM	Natera Acquires Reproductive Health Assets from Invitae (Business Wire)
07:00AM	Invitae Completes Sale of Reproductive Health Assets to Natera (PR Newswire)
Jan-18-24 08:00AM	Natera to Present New Data from the CIRCULATE-Japan and BESPOKE CRC Studies at ASCO GI 2024 Supporting Signateras Clinical Utility in CRC (Business Wire)
Jan-17-24 04:03PM	Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle (Investor's Business Daily) +7.30%
Jan-16-24 05:17PM	Natera Provides Update on Ravgen Trial (Business Wire)
Jan-09-24 07:00AM	Natera Announces Preliminary Fourth Quarter and Full Year 2023 Revenues (Business Wire)
Dec-30-23 11:01AM	Insider Sell: CFO Michael Brophy Sells 2,292 Shares of Natera Inc (NTRA) (GuruFocus.com)
Dec-29-23 08:00AM	Natera to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-27-23 11:48PM	Natera Wins Preliminary Injunction in Patent Infringement Lawsuit Against NeoGenomics RaDaR Test (Business Wire)
Dec-26-23 06:56PM	13 High Growth Healthcare Stocks to Buy (Insider Monkey)
Dec-21-23 08:00AM	Natera Announces New Study Highlighting the Benefits of Signateras Unique Method of Quantifying ctDNA (Business Wire) +5.25%
Dec-11-23 12:50PM	Delaware Court Denies CareDxs Motion for Summary Judgment on Two Natera Patents (Business Wire)
Dec-10-23 11:59AM	12 Best Genomics Stocks To Buy Now (Insider Monkey)
Dec-06-23 08:30AM	Natera Presents New Signatera MRD Data Across Breast Cancer Treatment Settings at SABCS 2023 (Business Wire)
Dec-02-23 07:06AM	Insider Sell Alert: Director Rowan Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Nov-23-23 11:03AM	Insider Sell: CEO Steven Chapman Sells Shares of Natera Inc (NTRA) (GuruFocus.com)
Nov-14-23 08:00AM	Natera Announces Real-World Data Collaboration with Merck (Business Wire) +7.38%
Nov-13-23 11:24AM	Natera, Inc. (NASDAQ:NTRA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:02PM	Natera: Q3 Earnings Snapshot (Associated Press Finance) -5.27% +9.80%
04:05PM	Natera Reports Third Quarter 2023 Financial Results (Business Wire)
09:10AM	Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer (Business Wire)
Nov-07-23 08:30AM	Natera to Participate in November Investor Conferences (Business Wire)
Nov-02-23 08:30AM	Nateras Landmark RenaCARE Study Demonstrates Significant Diagnostic and Clinical Utility of Renasight in Chronic Kidney Disease (Business Wire)

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chapman Steven Leonard	CEO AND PRESIDENT	Jun 17 '24	Sale	111.61	6,105	681,372	213,351	Jun 18 09:35 PM
Marcus Gail Boxer	Director	May 30 '24	Sale	110.17	2,000	220,330	18,634	May 31 09:05 PM
Chapman Rowan E	Director	May 28 '24	Sale	109.09	4,856	529,728	5,005	May 30 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	May 28 '24	Sale	109.96	1,647	181,103	114,186	May 30 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	May 28 '24	Sale	109.96	1,438	158,122	109,940	May 30 09:05 PM
Sheena Jonathan	CO-FOUNDER	May 23 '24	Sale	108.30	1,000	108,301	68,582	May 24 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	May 15 '24	Sale	107.08	6,779	725,911	219,456	May 17 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	May 10 '24	Option Exercise	19.68	30,000	590,400	234,495	May 10 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	May 10 '24	Sale	104.59	30,000	3,137,567	204,495	May 10 09:35 PM
Sheena Jonathan	CO-FOUNDER	May 10 '24	Sale	105.11	2,700	283,794	319,061	May 10 09:35 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	May 08 '24	Option Exercise	5.40	215,000	1,159,990	1,290,648	May 10 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	May 01 '24	Sale	93.97	1,866	175,344	67,542	May 03 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 29 '24	Sale	93.14	4,084	380,378	226,235	May 01 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 29 '24	Sale	93.14	1,238	115,306	69,408	May 01 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 29 '24	Sale	93.14	1,196	111,394	115,833	May 01 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Apr 29 '24	Sale	93.14	1,057	98,448	204,495	May 01 09:05 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Apr 29 '24	Sale	93.14	929	86,526	110,748	May 01 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 26 '24	Sale	92.00	751	69,092	70,646	Apr 26 09:35 PM
Sheena Jonathan	CO-FOUNDER	Apr 25 '24	Sale	89.55	1,000	89,550	69,082	Apr 26 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 25 '24	Sale	89.55	705	63,133	71,397	Apr 26 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 24 '24	Sale	93.00	937	87,140	72,102	Apr 26 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 23 '24	Sale	91.38	2,552	233,200	230,319	Apr 23 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 23 '24	Sale	91.38	1,523	139,171	73,039	Apr 23 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Apr 23 '24	Sale	91.38	787	71,915	205,552	Apr 23 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 23 '24	Sale	91.38	531	48,522	117,029	Apr 23 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Apr 23 '24	Sale	91.38	522	47,700	111,677	Apr 23 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Apr 16 '24	Sale	90.82	80,000	7,265,651	117,560	Apr 17 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Apr 15 '24	Sale	93.13	6,816	634,797	227,710	Apr 17 09:05 PM
Sheena Jonathan	CO-FOUNDER	Apr 03 '24	Sale	92.47	26,700	2,468,822	321,031	Apr 04 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Apr 02 '24	Sale	92.62	1,378	127,629	70,646	Apr 04 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 28 '24	Sale	90.42	2,662	240,687	234,526	Mar 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Mar 28 '24	Sale	90.13	1,000	90,130	69,582	Mar 29 09:35 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Mar 28 '24	Sale	90.42	914	82,640	72,024	Mar 29 09:35 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Mar 28 '24	Sale	90.42	743	67,179	204,839	Mar 29 09:35 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Mar 28 '24	Sale	90.42	707	63,924	197,560	Mar 29 09:35 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Mar 28 '24	Sale	90.42	464	41,953	112,199	Mar 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Mar 28 '24	Sale	90.22	447	40,326	347,731	Mar 29 09:35 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Option Exercise	19.37	68,270	1,322,406	315,227	Mar 15 09:05 PM
BOTHA ROELOF	Director	Mar 15 '24	Option Exercise	42.17	19,924	840,197	20,276	Mar 15 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Sale	88.96	83,223	7,403,534	232,004	Mar 15 09:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 15 '24	Sale	89.02	50,910	4,532,065	0	Mar 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Mar 06 '24	Sale	88.70	5,000	443,492	458,585	Mar 07 09:40 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Mar 05 '24	Sale	87.40	190,000	16,605,069	860,036	Mar 07 09:40 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Mar 05 '24	Sale	88.36	9,326	824,092	246,957	Mar 07 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Mar 05 '24	Sale	88.36	2,826	249,719	70,646	Mar 07 09:40 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Mar 05 '24	Sale	88.36	2,245	198,361	198,267	Mar 07 09:40 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Mar 05 '24	Sale	88.36	2,160	190,868	204,218	Mar 07 09:40 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Mar 05 '24	Sale	88.36	1,838	162,400	112,663	Mar 07 09:40 PM
Sheena Jonathan	CO-FOUNDER	Mar 05 '24	Sale	88.36	1,028	90,839	463,585	Mar 07 09:40 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Mar 05 '24	Sale	88.36	1,012	89,416	1,075,648	Mar 07 09:40 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 29 '24	Option Exercise	9.29	20,526	190,687	224,744	Feb 29 09:15 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 29 '24	Sale	89.01	20,526	1,826,970	204,218	Feb 29 09:15 PM
Sheena Jonathan	CO-FOUNDER	Feb 29 '24	Sale	86.34	10,000	863,433	463,585	Mar 01 08:45 PM
Sheena Jonathan	CO-FOUNDER	Feb 29 '24	Sale	90.02	6,000	540,109	14,655	Mar 01 08:45 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 27 '24	Option Exercise	10.16	35,307	358,802	239,525	Feb 29 09:15 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Feb 27 '24	Sale	75.09	35,307	2,651,298	204,218	Feb 29 09:15 PM
Rabinowitz Matthew	EXECUTIVE CHAIRMAN	Feb 23 '24	Option Exercise	2.66	380,036	1,009,718	1,050,036	Feb 23 09:40 PM
ROSENMAN HERM	Director	Feb 16 '24	Option Exercise	2.66	93,901	249,486	155,586	Feb 16 09:45 PM
ROSENMAN HERM	Director	Feb 16 '24	Sale	69.37	93,901	6,514,371	61,685	Feb 16 09:45 PM
Sheena Jonathan	CO-FOUNDER	Feb 07 '24	Sale	70.10	5,000	350,486	473,585	Feb 08 09:05 PM
Sheena Jonathan	CO-FOUNDER	Feb 07 '24	Sale	70.10	1,000	70,099	17,655	Feb 08 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 06 '24	Option Exercise	16.61	34,029	565,063	104,675	Feb 08 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 06 '24	Sale	70.03	34,029	2,383,129	70,646	Feb 08 09:40 PM
Sheena Jonathan	CO-FOUNDER	Feb 06 '24	Sale	70.00	6,000	420,011	18,155	Feb 08 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Feb 01 '24	Sale	67.73	22,281	1,509,081	70,646	Feb 02 09:40 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jan 29 '24	Sale	65.09	14,813	964,194	246,957	Jan 30 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jan 29 '24	Sale	65.09	4,265	277,614	204,218	Jan 30 09:05 PM
Moshkevich Solomon	PRESIDENT, CLINICALDIAGNOSTICS	Jan 29 '24	Sale	65.09	3,426	223,002	194,977	Jan 30 09:02 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jan 29 '24	Sale	65.09	3,235	210,570	92,927	Jan 30 09:15 PM
Fesko John	PRESIDENT, CHIEF BUS. OFFICER	Jan 29 '24	Sale	65.09	2,358	153,485	108,494	Jan 30 08:57 PM
Sheena Jonathan	CO-FOUNDER	Jan 29 '24	Sale	65.09	546	35,540	478,585	Jan 30 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jan 24 '24	Sale	67.00	944	63,248	64,810	Jan 26 09:40 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jan 23 '24	Sale	65.86	2,202	145,014	65,754	Jan 23 09:45 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Jan 22 '24	Sale	68.16	1,958	133,457	175,550	Jan 23 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Jan 22 '24	Sale	68.16	892	60,799	181,050	Jan 23 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Jan 22 '24	Sale	68.16	771	52,551	67,956	Jan 23 09:45 PM
Sheena Jonathan	CO-FOUNDER	Jan 22 '24	Sale	68.16	351	23,924	469,726	Jan 23 09:05 PM
Sheena Jonathan	CO-FOUNDER	Jan 03 '24	Sale	60.30	5,000	301,499	469,743	Jan 05 08:05 PM
Sheena Jonathan	CO-FOUNDER	Jan 03 '24	Sale	60.45	1,000	60,451	21,155	Jan 05 08:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Dec 29 '23	Sale	62.29	1,377	85,773	64,810	Dec 29 09:45 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Dec 28 '23	Sale	63.29	2,604	164,813	172,348	Dec 29 09:35 PM
Sheena Jonathan	CO-FOUNDER	Dec 28 '23	Sale	62.12	1,000	62,120	21,655	Dec 29 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Dec 28 '23	Sale	63.29	915	57,912	66,187	Dec 29 09:45 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Dec 28 '23	Sale	63.29	728	46,077	180,442	Dec 29 09:05 PM
Sheena Jonathan	CO-FOUNDER	Dec 28 '23	Sale	62.44	447	27,909	474,743	Dec 29 09:05 PM
HEALY JAMES	Director	Dec 13 '23	Sale	58.75	644,000	37,835,000	0	Dec 22 02:21 PM
Marcus Gail Boxer	Director	Dec 08 '23	Sale	57.52	500	28,760	20,146	Dec 12 08:35 PM
Sheena Jonathan	CO-FOUNDER	Dec 06 '23	Sale	58.22	5,000	291,078	474,743	Dec 08 08:35 PM
Chapman Rowan E	Director	Nov 29 '23	Sale	55.97	1,998	111,831	9,373	Dec 01 08:35 PM
Marcus Gail Boxer	Director	Nov 21 '23	Sale	54.31	1,000	54,314	20,646	Nov 22 08:05 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Nov 20 '23	Sale	55.00	2,566	141,130	217,554	Nov 22 08:05 PM
Sheena Jonathan	CO-FOUNDER	Nov 02 '23	Sale	40.23	5,000	201,150	479,743	Nov 03 09:05 PM
Sheena Jonathan	CO-FOUNDER	Nov 02 '23	Sale	40.35	1,000	40,351	22,155	Nov 03 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Oct 23 '23	Sale	40.40	3,940	159,195	64,810	Oct 24 09:45 PM
Chapman Steven Leonard	CEO AND PRESIDENT	Oct 23 '23	Sale	40.39	2,595	104,813	220,120	Oct 24 09:35 PM
Sheena Jonathan	CO-FOUNDER	Oct 23 '23	Sale	40.04	1,000	40,037	22,655	Oct 24 09:05 PM
RABINOWITZ DANIEL	SEC. AND CHIEF LEGAL OFFICER	Oct 23 '23	Sale	40.39	803	32,433	179,807	Oct 24 09:05 PM
Sheena Jonathan	CO-FOUNDER	Oct 23 '23	Sale	40.19	335	13,464	484,743	Oct 24 09:05 PM
Brophy Michael Burkes	CHIEF FINANCIAL OFFICER	Sep 29 '23	Sale	45.98	1,372	63,080	64,833	Sep 29 09:45 PM
Sheena Jonathan	CO-FOUNDER	Sep 28 '23	Sale	46.06	5,448	250,909	484,745	Sep 29 09:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NTRA

Natera Inc

Upgrade your FINVIZ experience